{"product_id":"reta-glp-3-50mg","title":"RETA (GLP-3) 50mg","description":"\u003cdiv style=\"background-color: #1a2744; border-radius: 8px; padding: 16px 20px; margin-bottom: 16px; display: flex; align-items: center; gap: 14px;\"\u003e\n\u003cspan style=\"font-size: 24px; color: #ffffff;\"\u003e✔\u003c\/span\u003e\n\u003cdiv\u003e\n\u003cp style=\"margin: 0; color: #ffffff; font-weight: bold; font-size: 15px;\"\u003eBacteriostatic (BAC) Water Included\u003c\/p\u003e\n\u003cp style=\"margin: 4px 0 0; color: #c8d0e0; font-size: 13px;\"\u003eNo separate purchase required\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cdiv style=\"display: flex; flex-wrap: wrap; gap: 8px; margin-bottom: 16px; justify-content: center;\"\u003e\n\u003cspan style=\"background-color: #eef1f7; color: #1a2744; font-size: 12px; font-weight: 600; padding: 5px 12px; border-radius: 20px; letter-spacing: 0.03em;\"\u003e\u003cstrong\u003eTriple-Receptor Metabolic Research\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"background-color: #eef1f7; color: #1a2744; font-size: 12px; font-weight: 600; padding: 5px 12px; border-radius: 20px; letter-spacing: 0.03em;\"\u003e\u003cstrong\u003eGLP-1\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"background-color: #eef1f7; color: #1a2744; font-size: 12px; font-weight: 600; padding: 5px 12px; border-radius: 20px; letter-spacing: 0.03em;\"\u003e\u003cstrong\u003eGIP\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"background-color: #eef1f7; color: #1a2744; font-size: 12px; font-weight: 600; padding: 5px 12px; border-radius: 20px; letter-spacing: 0.03em;\"\u003e\u003cstrong\u003eGlucagon\u003c\/strong\u003e\u003c\/span\u003e\n\u003c\/div\u003e\u003ch4\u003e\u003cstrong\u003eWhat is RETA (GLP-3)?\u003c\/strong\u003e\u003c\/h4\u003e\u003cdiv style=\"background-color: #f0f3f8; border-left: 4px solid #1a2744; border-radius: 4px; padding: 14px 18px; margin-bottom: 16px;\"\u003e\u003cp\u003eRETA (GLP-3) is an investigational metabolic peptide being studied for activity across three important hormonal receptor pathways: GLP-1, GIP and glucagon.\u003c\/p\u003e\u003c\/div\u003e\u003cp\u003eThis triple-receptor activity makes RETA (GLP-3) a particularly interesting area of metabolic research, allowing researchers to investigate several interconnected pathways involved in energy balance, glucose regulation, appetite signalling, metabolic function and body composition.\u003c\/p\u003e\u003cp\u003eUnlike compounds that primarily investigate one metabolic signalling pathway, RETA (GLP-3) provides a research model involving three complementary receptor systems within a single molecule.\u003c\/p\u003e\u003cp\u003eRETA (GLP-3) continues to be investigated in clinical and laboratory research, with researchers studying its mechanisms, metabolic effects and longer-term characteristics.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eWhy is RETA (GLP-3) interesting?\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eThe three receptor pathways associated with RETA (GLP-3) each play important roles in metabolic biology.\u003c\/p\u003e\u003cp\u003eGLP-1 signalling is associated with glucose-dependent insulin secretion, appetite signalling and gastrointestinal regulation.\u003c\/p\u003e\u003cp\u003eGIP signalling is involved in nutrient sensing and glucose-dependent insulin secretion and is being investigated for its broader effects on metabolic regulation.\u003c\/p\u003e\u003cp\u003eGlucagon receptor signalling plays an important role in hepatic metabolism, energy mobilisation and the body's response to changing energy demands.\u003c\/p\u003e\u003cp\u003eThe ability to investigate these three pathways together is what makes RETA (GLP-3) particularly interesting within modern metabolic research.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eRETA (GLP-3) \u0026amp; GLP-1 Signalling\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eGLP-1 is a naturally occurring hormone released in response to food intake and plays an important role in glucose homeostasis.\u003c\/p\u003e\u003cp\u003eGLP-1 receptor signalling has been investigated in relation to:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eGlucose-dependent insulin secretion\u003c\/li\u003e\n\u003cli\u003eAppetite regulation\u003c\/li\u003e\n\u003cli\u003eGastrointestinal activity\u003c\/li\u003e\n\u003cli\u003eGlucose metabolism\u003c\/li\u003e\n\u003cli\u003eNutrient signalling\u003c\/li\u003e\n\u003cli\u003eEnergy balance\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eRETA (GLP-3) allows researchers to investigate GLP-1 receptor activity alongside GIP and glucagon receptor signalling, creating an opportunity to study the interaction between these different metabolic pathways.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eRETA (GLP-3) \u0026amp; GIP Signalling\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eGIP, or glucose-dependent insulinotropic polypeptide, is another naturally occurring incretin hormone involved in the body's response to nutrient intake.\u003c\/p\u003e\u003cp\u003eGIP signalling is being investigated in relation to glucose metabolism, insulin secretion, nutrient sensing and broader metabolic processes.\u003c\/p\u003e\u003cp\u003eOne area of interest is how GIP signalling interacts with GLP-1 signalling and whether these pathways can produce complementary metabolic effects when investigated together.\u003c\/p\u003e\u003cp\u003eRETA (GLP-3) provides researchers with a model for exploring this interaction alongside glucagon receptor activity.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eRETA (GLP-3) \u0026amp; Glucagon\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eGlucagon is an important hormone involved in maintaining energy availability and regulating hepatic metabolism.\u003c\/p\u003e\u003cp\u003eGlucagon receptor activity is associated with processes involved in:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eEnergy mobilisation\u003c\/li\u003e\n\u003cli\u003eHepatic glucose regulation\u003c\/li\u003e\n\u003cli\u003eSubstrate utilisation\u003c\/li\u003e\n\u003cli\u003eEnergy expenditure\u003c\/li\u003e\n\u003cli\u003eMetabolic adaptation\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eThe addition of glucagon receptor activity is one of the features that distinguishes RETA (GLP-3) from research compounds that primarily focus on incretin signalling alone.\u003c\/p\u003e\u003cp\u003eResearchers are interested in understanding how glucagon signalling interacts with GLP-1 and GIP pathways to influence overall metabolic regulation.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eRETA (GLP-3) \u0026amp; Metabolic Research\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eMetabolic research involves a complex network of hormones and signalling pathways that regulate how the body responds to food intake, energy availability and changing metabolic demands.\u003c\/p\u003e\u003cp\u003eRETA (GLP-3) has attracted considerable research interest because of its triple-receptor mechanism.\u003c\/p\u003e\u003cp\u003eCurrent research has explored areas including:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eBody-weight regulation\u003c\/li\u003e\n\u003cli\u003eAppetite signalling\u003c\/li\u003e\n\u003cli\u003eGlucose regulation\u003c\/li\u003e\n\u003cli\u003eEnergy balance\u003c\/li\u003e\n\u003cli\u003eMetabolic health\u003c\/li\u003e\n\u003cli\u003eBody composition\u003c\/li\u003e\n\u003cli\u003eInsulin-related pathways\u003c\/li\u003e\n\u003cli\u003eEnergy expenditure\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eClinical research continues to investigate the compound across different populations and metabolic conditions, while its longer-term safety and characteristics remain areas of ongoing study.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eRETA (GLP-3) \u0026amp; Appetite Research\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eAppetite is regulated by a complex network of hormonal and neurological signals.\u003c\/p\u003e\u003cp\u003eGLP-1 and GIP signalling are both involved in nutrient-related hormonal responses, while glucagon signalling contributes to broader energy regulation.\u003c\/p\u003e\u003cp\u003eRETA (GLP-3) provides researchers with an opportunity to investigate how simultaneous activity across these three pathways may influence appetite-related signalling, food intake and energy balance.\u003c\/p\u003e\u003cp\u003eThis makes appetite and satiety research an important area within the broader study of RETA (GLP-3).\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eRETA (GLP-3) \u0026amp; Energy Balance\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eEnergy balance describes the relationship between energy intake and energy expenditure.\u003c\/p\u003e\u003cp\u003eMultiple hormonal pathways contribute to this process, including GLP-1, GIP and glucagon signalling.\u003c\/p\u003e\u003cp\u003eRETA (GLP-3) is particularly interesting to metabolic researchers because it brings these pathways together within one investigational molecule.\u003c\/p\u003e\u003cp\u003eResearch in this area is helping scientists explore the relationship between nutrient intake, energy expenditure, fuel utilisation and metabolic signalling.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eRETA (GLP-3) \u0026amp; Body Composition Research\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eBody composition research looks beyond total body weight to investigate changes in components such as fat mass, lean mass and overall metabolic parameters.\u003c\/p\u003e\u003cp\u003eThe metabolic pathways associated with RETA (GLP-3) have generated interest in research examining changes in body composition alongside broader metabolic outcomes.\u003c\/p\u003e\u003cp\u003eResearchers continue to investigate how triple-receptor activity may influence energy balance and body-composition-related measurements.\u003c\/p\u003e\u003cp\u003eImportantly, research findings from clinical studies should be interpreted within the specific population, study design and conditions in which they were obtained.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eRETA (GLP-3) \u0026amp; Glucose Research\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eGlucose regulation is one of the major areas of interest surrounding GLP-1 and GIP signalling.\u003c\/p\u003e\u003cp\u003eBoth pathways are involved in glucose-dependent insulin secretion, while glucagon plays an important role in maintaining glucose availability and hepatic metabolism.\u003c\/p\u003e\u003cp\u003eStudying these pathways simultaneously allows researchers to investigate the interaction between incretin signalling, insulin-related responses and glucagon activity.\u003c\/p\u003e\u003cp\u003eThis provides a valuable research model for exploring broader mechanisms involved in metabolic regulation.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eWhat makes RETA (GLP-3) different?\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTriple-receptor activity:\u003c\/strong\u003e Research involving GLP-1, GIP and glucagon receptor pathways simultaneously.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic signalling:\u003c\/strong\u003e Investigation into several interconnected pathways involved in metabolic regulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAppetite research:\u003c\/strong\u003e Exploration of hormonal pathways involved in food intake and satiety.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnergy-balance research:\u003c\/strong\u003e Investigation into the relationship between energy intake, expenditure and fuel utilisation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlucose research:\u003c\/strong\u003e Study of pathways involved in glucose-dependent insulin and glucagon signalling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBody-composition research:\u003c\/strong\u003e Investigation into metabolic and body-composition-related outcomes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMulti-pathway model:\u003c\/strong\u003e Allows researchers to investigate three major metabolic signalling systems within one investigational molecule.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003e\u003cstrong\u003eA New Direction in Metabolic Research\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eRETA (GLP-3) represents an interesting direction in metabolic peptide research because it brings together three major hormonal pathways within a single investigational molecule.\u003c\/p\u003e\u003cp\u003eRather than focusing exclusively on one receptor system, RETA (GLP-3) allows researchers to investigate the interaction between GLP-1, GIP and glucagon signalling.\u003c\/p\u003e\u003cp\u003eAs metabolic science continues to evolve, research into these interconnected pathways may provide further insight into how hormonal signalling influences energy balance, glucose regulation, appetite, metabolism and body composition.\u003c\/p\u003e\u003cp\u003eResearch continues to examine the compound's mechanisms, metabolic effects and longer-term characteristics.\u003c\/p\u003e\u003cp\u003ePeptigen RETA (GLP-3) 50mg is supplied strictly for laboratory research purposes.\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eRETA (GLP-3) 50mg — Research Areas at a Glance\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eGLP-1 Signalling • GIP Signalling • Glucagon Receptor • Metabolic Regulation • Appetite Research • Energy Balance • Glucose Research • Body Composition • Energy Expenditure\u003c\/p\u003e\u003ch4\u003e\u003cstrong\u003eProduct Details\u003c\/strong\u003e\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eProduct:\u003c\/strong\u003e RETA (GLP-3)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSize:\u003c\/strong\u003e 50mg per vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBAC Water:\u003c\/strong\u003e Included\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised research compound\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrice:\u003c\/strong\u003e R2,250.00\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIntended use:\u003c\/strong\u003e Laboratory and scientific research only\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003e\u003cstrong\u003eResearch Disclaimer\u003c\/strong\u003e\u003c\/h4\u003e\u003cp\u003eRETA (GLP-3) is an investigational research compound and is not currently approved by SAHPRA, the FDA, or other major regulatory authorities for therapeutic or consumer applications.\u003c\/p\u003e\u003cp\u003ePeptigen products are provided exclusively for laboratory research. Information on this website is presented for general scientific and educational purposes and should not be considered medical advice, a treatment recommendation, or guidance for personal use.\u003c\/p\u003e\u003cp\u003eResearch involving RETA (GLP-3) continues to develop, and research findings should always be interpreted within the context of the specific study, population, research model and conditions under which they were obtained.\u003c\/p\u003e\u003cp\u003ePeptigen does not provide dosing, administration or reconstitution guidance for research compounds. Purchasers are responsible for ensuring that research materials are handled within an appropriate research environment and in accordance with relevant laws, regulations, laboratory protocols and safety requirements.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch use only.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePeptigen.\u003c\/strong\u003e\u003cbr\u003eQuality. Research. Potential.\u003c\/p\u003e","brand":"PEPTIGEN","offers":[{"title":"Default Title","offer_id":67514907132145,"sku":null,"price":2250.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0807\/3982\/7953\/files\/reta-50mg-891c8221.png?v=1794577096","url":"https:\/\/peptigen.co.za\/products\/reta-glp-3-50mg","provider":"PEPTIGEN","version":"1.0","type":"link"}